SCHEMBL4957466

SCHEMBL4957466

O=C(Nc1nc2c(s1)CCc1ccccc1-2)c1cnccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.61
MAPT P10636 9/20 0.61
KMT2A Q03164 7/20 0.61
LMNA P02545 6/20 0.61
MEN1 O00255 6/20 0.61
RAB9A P51151 4/20 0.61
NPC1 O15118 3/20 0.61
NPSR1 Q6W5P4 3/20 0.61
HTT P42858 2/20 0.61
USP2 O75604 1/20 0.61
SMN1; SMN2 Q16637 5/20 0.60
ALDH1A1 P00352 5/20 0.60
HSD17B10 Q99714 2/20 0.60
XIAP P98170 1/20 0.56
ALOX5 P09917 1/20 0.55
KDM4E B2RXH2 5/20 0.51
HPGD P15428 5/20 0.51
THRB P10828 1/20 0.50
ALOX12 P18054 1/20 0.49
NFKB1 P19838 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4958208 0.94 POLB (0.54) POLBMAPTKMT2ALMNAMEN1
SCHEMBL4957325 0.84 MAPT (0.71) POLBMAPTKMT2ALMNAMEN1
SCHEMBL4958307 0.83 MAPT (0.71) MAPTKMT2ALMNAMEN1RAB9A
SCHEMBL4960420 0.79 MAPT (0.64) POLBMAPTKMT2ALMNAMEN1
SCHEMBL4958817 0.78 MAPT (0.52) MAPTKMT2ALMNAMEN1RAB9A
SCHEMBL4960241 0.75 ADORA1 (0.61) POLBMAPTKMT2ALMNAMEN1
SCHEMBL4963803 0.75 MAPT (0.67) POLBMAPTKMT2ALMNAMEN1
SCHEMBL2305783 0.74 POLB (0.61) POLBMAPTKMT2ALMNAMEN1
SCHEMBL1746834 0.74 ALOX5 (0.77) POLBMAPTKMT2ALMNAMEN1
SCHEMBL4959609 0.73 MAPT (0.71) POLBMAPTKMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US claimed
CN-1993336-A Substituted n-acyl-2-aminothiazoles HOFFMANN LA ROCHE (CH) 2007-07-04 CN claimed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP claimed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US claimed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO claimed
US-7407977-B2 Substituted N-acyl-2-aminothiazoles HOFFMAN-LA ROCHE INC. (US) 2008-08-05 US disclosed
CN-1993336-A Substituted n-acyl-2-aminothiazoles HOFFMANN LA ROCHE (CH) 2007-07-04 CN disclosed
EP-1791822-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F.HOFFMANN-LA ROCHE AG (CH) 2007-06-06 EP disclosed
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles HOFFMANN-LA ROCHE INC. 2006-02-09 US disclosed
WO-2006013054-A1 SUBSTITUTED N-ACYL-2-AMINOTHIAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030589-A1 Substituted N-acyl-2-aminothiazoles SLC5A2, ABAT, AGTR2 POLB 3667/4885MAPT 1360/4885KMT2A 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.